Scott Kirby, United Airlines CEO, joins 'CERAWeek' to discuss the airline industry trends, flight demand and FAA shortages.
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Ingram Micro Holding Corporation (“Ingram” or the “Company”) (NYSE:IN
With KEX's shares appreciating lately, we assess the stock's current positioning to determine whether it's a good investment choice at this juncture.
NEW YORK--(BUSINESS WIRE)---- $TTD #CLASSACTIONLAWSUIT--The law firm of Kirby McInerney LLP reminds investors who purchased The Trade Desk, Inc. (“TTD” or the “Company”) (NASDAQ:TTD) securitie
WMS to deliver advanced functionality for electrical distribution. MONTREAL , Feb. 26, 2025 /PRNewswire/ -- Tecsys Inc. (TSX: TCS), a global leader in supply chain management software, today announced
Kirby Corporation demonstrates resilience amid market volatility through prudent pricing, cost efficiency, and strategic investments in new barges, stabilizing top-line growth. Despite softer global d
NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors who purchased Venture Global Inc. (“Venture” or the “Company”) (NYSE:VG) securities to contact
NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the March 31, 2025, deadline to seek the role of lead plaintiff in a federal securities class actio
NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Septerna, Inc. (“Septerna” or the “Company”) (NASDAQ:SEPN). The invest
NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Everus Construction Group, Inc. (“Everus” or the “Company”) (NYSE:ECG)
NEW YORK--(BUSINESS WIRE)---- $VG #CLASSACTIONLAWSUIT--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of
SAN CARLOS, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclona
KEX's fourth-quarter 2024 earnings and revenues increase year over year.
Kirby Corporation (NYSE:KEX ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Kurt Niemietz - VP, IR & Treasurer David Grzebinski - CEO Raj Kumar - CFO Christian O'Ne
NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP notifies investors of the approaching February 7, 2025, deadline to seek the role of lead plaintiff in a federal securit
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE